Propanc Biopharma, Inc. (PPCB) SEC Filings — 2025

Filings

• Propanc Biopharma Files S-1 for $1M Capital Raise, Faces Going Concern Doubt — S-1 · Dec 30, 2025
• Propanc Biopharma's Q1 Loss Skyrockets on Soaring Admin Costs — 10-Q · Nov 14, 2025
• Propanc Biopharma Files 8-K on Equity Sales & Amendments — 8-K · Nov 10, 2025
• Propanc Biopharma Enters Material Definitive Agreement — 8-K · Oct 14, 2025
• Propanc Biopharma Pushes Ahead with Cancer Stem Cell Therapy — 10-K · Sep 29, 2025
• Propanc Biopharma Reports Key Corporate Events — 8-K · Aug 19, 2025
• Propanc Biopharma Reports Officer and Director Changes — 8-K · Aug 13, 2025
• Propanc Biopharma Files 8-K: Agreements & Equity Sales — 8-K · Jul 30, 2025
• Propanc Biopharma Amends S-1/A, Deepens Losses Amid R&D Push — S-1/A · Jul 28, 2025
• Propanc Biopharma Reports Material Agreement & Equity Sales — 8-K · Jul 22, 2025
• Propanc Biopharma Files 8-K: Material Agreement, Debt, Equity Sales — 8-K · Jun 27, 2025
• Propanc Biopharma Files 8-K: Material Agreement, Debt, Equity Sales — 8-K · Jun 18, 2025
• Propanc Biopharma Files 8-K: Material Agreement & Equity Sales — 8-K · Jun 2, 2025
• Propanc Biopharma Amends S-1/A, Details Capital Structure — S-1/A · May 30, 2025
• Propanc Biopharma Files 10-Q for Q3 2025 — 10-Q · May 15, 2025
• Propanc Biopharma Reports Definitive Agreement and Equity Sales — 8-K · May 8, 2025
• Propanc Biopharma Files S-1/A Amendment — S-1/A · Apr 25, 2025
• Propanc Biopharma Files 8-K on Agreements and Equity Sales — 8-K · Apr 21, 2025
• Propanc Biopharma Files S-1/A — S-1/A · Apr 8, 2025
• Propanc Biopharma Files S-1/A — S-1/A · Apr 2, 2025
• Propanc Biopharma Files S-1/A — S-1/A · Mar 31, 2025
• Propanc Biopharma Files 8-K: Material Agreement & Equity Sales — 8-K · Mar 18, 2025
• Propanc Biopharma Files 10-Q for Q2 FY2025 — 10-Q · Feb 14, 2025
• Propanc Biopharma Files 8-K: Material Agreement & Equity Sales — 8-K · Feb 12, 2025